Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Completed Phase 2 Trials for Etoposide (DB00773)

IndicationStatusPhase
DBCOND0028534 (Adult Acute Minimally Differentiated Myeloid Leukemia (M0))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00602771Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid LeukemiaTreatment
NCT00634244Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaTreatment